Home Total Parenteral Nutrition for Intestinal Failure in Patients with Advanced Small Intestinal Neuroendocrine Neoplasms

References

• Mitchell J, Jatoi A. Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider. Semin Oncol. 2011;38(3):439–442. doi:10.1053/j.seminoncol.2011.03.020
   PubMed Web of Science ®Google Scholar
• Weiner RS, Kramer BS, Clamon GH, Feld R, Evans W, Moran EM, Blum R, Weisenthal LM, Pee D, Hoffman FA, et al. Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer. J Clin Oncol. 1985;3(7):949–957. doi:10.1200/JCO.1985.3.7.949
   PubMed Web of Science ®Google Scholar
• Shamberger RC, Brennan MF, Goodgame JT, Lowry SF, Maher MM, Wesley RA, Pizzo PA. A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas: results of metabolic and survival studies. Surgery. 1984;96(1):1–13.
   PubMed Web of Science ®Google Scholar
• McGeer AJ, Detsky AS, O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition. 1990;6(3):233–240.
   PubMed Web of Science ®Google Scholar
• Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape U-F, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172–185. doi:10.1159/000443167
   PubMed Web of Science ®Google Scholar
• Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–1786. doi:10.1038/s41379-018-0110-y
   PubMed Web of Science ®Google Scholar
• Cheung VTF, Khan MS. A guide to midgut neuroendocrine tumours (NETs) and carcinoid syndrome. Frontline Gastroenterol. 2015;6(4):264–269. doi:10.1136/flgastro-2014-100483
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey J-N, Rashid A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–3072. doi:10.1200/JCO.2007.15.4377
   PubMed Web of Science ®Google Scholar
• Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. J Oncol Pract. 2018;14(8):471–82. doi:10.1200/JOP.18.00135
   PubMed Web of Science ®Google Scholar
• Ter-Minassian M, Chan JA, Hooshmand SM, Brais LK, Daskalova A, Heafield R, Buchanan L, Qian ZR, Fuchs CS, Lin X, et al. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumours: results from a prospective institutional database. Endocr Relat Cancer. 2013;20(2):187–196. doi:10.1530/ERC-12-0340
   PubMed Web of Science ®Google Scholar
• Laskaratos F-M, Walker M, Wilkins D, Tuck A, Ramakrishnan S, Phillips E, Gertner J, Megapanou M, Papantoniou D, Shah R, et al. Evaluation of clinical prognostic factors and further delineation of the effect of mesenteric fibrosis on survival in advanced midgut neuroendocrine tumours. Neuroendocrinology. 2018;107(3):292–304. doi:10.1159/000493317
   PubMed Web of Science ®Google Scholar
• Woodbridge LR, Murtagh BM, Yu DFQC, Planche KL. Midgut neuroendocrine tumors: imaging assessment for surgical resection. Radiographics. 2014;34(2):413–426. doi:10.1148/rg.342135504
   PubMed Web of Science ®Google Scholar
• Fata CR, Gonzalez RS, Liu E, Cates JM, Shi C. Mesenteric tumour deposits in midgut small intestinal neuroendocrine tumours are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am J Surg Pathol. 2017;41(1):128–33.
   PubMed Web of Science ®Google Scholar
• Ramful S, Leyland H, Kirk C, Gemmell L, Mountford C, Thompson N. An experience of home total parenteral nutrition at the freeman hospital over a 21-year period. Gut. 2018;67(Suppl 1):A178.
   Google Scholar
• Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. Cancer. 2005;103(4):863–868. doi:10.1002/cncr.20824
   PubMed Web of Science ®Google Scholar
• Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi:10.1016/j.clnu.2016.07.015
   PubMed Web of Science ®Google Scholar
• Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, Jeppesen P, Moreno J, Hébuterne X, Pertkiewicz M, et al. ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009;28(4):467–479. doi:10.1016/j.clnu.2009.04.001
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN Guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009;28(4):445–454. doi:10.1016/j.clnu.2009.04.011
   PubMed Web of Science ®Google Scholar
• Mantzoros I, Savvala NA, Ioannidis O, Parpoudi S, Loutzidou L, Kyriakidou D, Cheva A, Intzos V, Tsalis K. Midgut neuroendocrine tumor presenting with acute intestinal ischemia. World J Gastroenterol. 2017;23(45):8090–8096. doi:10.3748/wjg.v23.i45.8090
   PubMed Web of Science ®Google Scholar
• Laskaratos F-M, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: an unsolved mystery? Cancer. 2017;123(24):4770–4790. doi:10.1002/cncr.31079
   PubMed Web of Science ®Google Scholar
• Blažević As, Hofland J, Hofland LJ, Feelders RA, de Herder WW. Small intestinal neuroendocrine tumours and fibrosiss: an entangled conundrum. Endocr Relat Cancer. 2018;25(3):R115–R130. doi:10.1530/ERC-17-0380
   PubMed Web of Science ®Google Scholar
• Mercadante S, Casuccio A, Mangione S. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage. 2007;33(2):217–223. doi:10.1016/j.jpainsymman.2006.06.014
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C, Tinivella M, Joly F, Jonkers C, Baxter J, et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol. 2014;25(2):487–493. doi:10.1093/annonc/mdt549
   PubMed Web of Science ®Google Scholar
• Bozzetti F. Nutritional support of the oncology patient. Crit Rev Oncol Hematol. 2013;87(2):172–200. doi:10.1016/j.critrevonc.2013.03.006
   PubMed Web of Science ®Google Scholar